Zefia Hall

Doctor of Osteopathic Medicine,  Mayo Clinic - Rochester 

Location: Africa

Consulting Services

Admin and Customer Support IT-Web-Mobile Technology Case Consulting Journal Manuscript

Areas Of Interest

Complex, Synaptonemal Grave Robbery Agents, Complement Inactivating Aural Rehabilitations Isophane Insulin Soybeans Galactoprotein b3 Tegafur Tumor Virus, Lucke Peach Palm Islet, Pancreatic Jatene Operation Radicava Receptor, Melatonin MT3 Meesmann Corneal Dystrophies Epilepsy, Rolandic Complementarity-Determining Regions Receptor, CCR1 Polymicrobial Infection Hydronephrosis Demon Possession HDL3 Lipoproteins Differentiation Antigens, B Cell Restrictive Cardiomyopathies Pharyngo-Esophageal Diverticula Anorectic Agents Schizosaccharomyce Joint, Intermetatarsal Dehydrogenases, Short Chain Acceleration Strains Animals, Inbred Neglect, Child Steroid Sulfatase Deficiency Hallucinations, Verbal Auditory Pyroxylin NSC 362856 Parvulin 14 Pain Questionnaire, McGill Embryo Death Birth, First

Professional Narrative

Dr. Zefia Hall was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Hall has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Medical Writer, Mayo Clinic 1991
Senior Director, Mayo Clinic 2001

Education

Doctor of medicine, Yale School of Medicine 2001
Doctor of osteopathic medicine, Yale School of Medicine 1998

Referees

Publications

Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O. Engineering Stem Cell Organoids. Cell Stem Cell. 2016 Jan 7;18(1):25-38. doi: 10.1016/j.stem.2015.12.005. PMID: 26748754; PMCID: PMC4728053.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02